You just read:

CorMatrix® Cardiovascular, Inc. receives FDA IDE approval to conduct the safety and feasibility clinical trial of the Cor™ TRICUSPID ECM® valve for pediatric and adult patients

News provided by

CorMatrix® Cardiovascular, Inc.

Jan 24, 2019, 10:07 ET